{
  "ticker": "ALNY",
  "company_name": "Alnylam Pharmaceuticals",
  "success": true,
  "trials": [
    {
      "nct_id": "NCT05577819",
      "title": "Prevalence and Prediction of ATTR in Ambulatory Patients With HFpEF",
      "status": "RECRUITING",
      "phase": "NA",
      "condition": "Transthyretin Amyloidosis, Heart Failure, Heart Failure, Diastolic, Amyloidosis",
      "start_date": "2020-10-02",
      "completion_date": "2026-12-31",
      "enrollment": 0,
      "sponsor": "Massachusetts General Hospital"
    },
    {
      "nct_id": "NCT04507269",
      "title": "Study of VIR-2218 in Patients With Chronic Hepatitis B in Mainland China",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Hepatitis B, Chronic",
      "start_date": "2020-08-18",
      "completion_date": "2021-09-30",
      "enrollment": 0,
      "sponsor": "Brii Biosciences Limited"
    },
    {
      "nct_id": "NCT03759379",
      "title": "HELIOS-A: A Study of Vutrisiran (ALN-TTRSC02) in Patients With Hereditary Transthyretin Amyloidosis (hATTR Amyloidosis)",
      "status": "COMPLETED",
      "phase": "PHASE3",
      "condition": "Amyloidosis, Hereditary, Transthyretin Amyloidosis",
      "start_date": "2019-02-14",
      "completion_date": "2025-11-05",
      "enrollment": 0,
      "sponsor": "Alnylam Pharmaceuticals"
    },
    {
      "nct_id": "NCT07181109",
      "title": "Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease",
      "status": "RECRUITING",
      "phase": "PHASE3",
      "condition": "High Risk Cardiovascular Disease, Hypertension, High Cardiovascular Risk",
      "start_date": "2025-09-22",
      "completion_date": "2030-10-29",
      "enrollment": 0,
      "sponsor": "Alnylam Pharmaceuticals"
    },
    {
      "nct_id": "NCT05761301",
      "title": "A Phase 1/2 Study to Evaluate ALN-KHK in Overweight to Obese Healthy Volunteers and Obese Patients With T2DM",
      "status": "TERMINATED",
      "phase": "PHASE1, PHASE2",
      "condition": "Type 2 Diabetes Mellitus (T2DM)",
      "start_date": "2023-03-10",
      "completion_date": "2025-04-03",
      "enrollment": 0,
      "sponsor": "Alnylam Pharmaceuticals"
    },
    {
      "nct_id": "NCT02292186",
      "title": "A Extension Study to Evaluate Revusiran (ALN-TTRSC) in Patients With Transthyretin (TTR) Cardiac Amyloidosis",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "TTR-mediated Amyloidosis",
      "start_date": "2014-10",
      "completion_date": "2017-02-22",
      "enrollment": 0,
      "sponsor": "Alnylam Pharmaceuticals"
    },
    {
      "nct_id": "NCT03547297",
      "title": "INSIGHT-AHP: A Study to Characterize the Prevalence of Acute Hepatic Porphyria (AHP) in Patients With Clinical Presentation and History Consistent With AHP",
      "status": "TERMINATED",
      "phase": "",
      "condition": "Acute Hepatic Porphyria, Hepatic Porphyrias, Acute Intermittent Porphyria (AIP), Hereditary Coproporphyria (HCP), Variegate Porphyria (VP), ALA Dehydratase Deficient Porphyria (ADP), Porphyria Acute",
      "start_date": "2018-05-29",
      "completion_date": "2019-01-15",
      "enrollment": 0,
      "sponsor": "Alnylam Pharmaceuticals"
    },
    {
      "nct_id": "NCT04569903",
      "title": "Evaluation of a Claims-based Algorithm for the Identification of Transthyretin-mediated Amyloidosis (ATTR) Amyloidosis in Medical Records",
      "status": "WITHDRAWN",
      "phase": "EARLY_PHASE1",
      "condition": "Transthyretin Amyloidosis",
      "start_date": "2022-08-01",
      "completion_date": "2025-02-01",
      "enrollment": 0,
      "sponsor": "Yale University"
    },
    {
      "nct_id": "NCT05231785",
      "title": "A Study to Evaluate the Safety and Tolerability of ALN-APP in Patients With EOAD",
      "status": "RECRUITING",
      "phase": "PHASE1",
      "condition": "Early-Onset Alzheimer Disease",
      "start_date": "2022-02-04",
      "completion_date": "2029-03-28",
      "enrollment": 0,
      "sponsor": "Alnylam Pharmaceuticals"
    },
    {
      "nct_id": "NCT02826018",
      "title": "A Study of ALN-HBV in Healthy Adult Volunteers and Non-cirrhotic Patients With Chronic Hepatitis B Virus (HBV) Infection",
      "status": "TERMINATED",
      "phase": "PHASE1",
      "condition": "Hepatitis B, Chronic Hepatitis B, Hepatitis B, Chronic, Hepatitis B Infection, HBV",
      "start_date": "2016-06-24",
      "completion_date": "2017-10",
      "enrollment": 0,
      "sponsor": "Alnylam Pharmaceuticals"
    }
  ],
  "summary": {
    "total_trials": 50,
    "by_phase": {
      "NA": 1,
      "PHASE2": 12,
      "PHASE3": 9,
      "PHASE1, PHASE2": 5,
      "": 10,
      "EARLY_PHASE1": 1,
      "PHASE1": 12
    },
    "by_status": {
      "RECRUITING": 10,
      "COMPLETED": 23,
      "TERMINATED": 7,
      "WITHDRAWN": 3,
      "UNKNOWN": 1,
      "ACTIVE_NOT_RECRUITING": 3,
      "NOT_YET_RECRUITING": 1,
      "APPROVED_FOR_MARKETING": 1,
      "NO_LONGER_AVAILABLE": 1
    },
    "active_trials": 13,
    "completed_trials": 23,
    "conditions": [
      "Acute Hepatic Porphyria",
      "Acute Hepatic Porphyria, Hepatic Porphyrias, Acute Intermittent Porphyria (AIP), Hereditary Coproporphyria (HCP), Variegate Porphyria (VP), ALA Dehydratase Deficient Porphyria (ADP), Porphyria Acute",
      "Advanced Hepatocellular Carcinoma, Metastatic Hepatocellular Carcinoma",
      "Alzheimer's Disease",
      "Amyloidosis, Familial, Transthyretin Amyloidosis",
      "Amyloidosis, Hereditary, Transthyretin Amyloidosis",
      "Atypical Hemolytic Uremic Syndrome",
      "Chronic Hepatitis B",
      "Chronic Inflammatory Demyelinating Polyneuropathy, Guillain-Barre Syndrome, Hereditary Amyloidosis",
      "Early-Onset Alzheimer Disease",
      "Familial Amyloidotic Cardiomyopathy (FAC)",
      "Gout",
      "Haemodialysis, Chronic Kidney Disease Requiring Chronic Dialysis, Cardiovascular Disease, Cardiovascular Risk Factor, Hyperoxalemia",
      "Healthy Volunteers",
      "Hepatitis B, Chronic",
      "Hepatitis B, Chronic Hepatitis B, Hepatitis B, Chronic, Hepatitis B Infection, HBV",
      "Hereditary Transthyretin-mediated (ATTRv) Amyloidosis, Polyneuropathy",
      "Hereditary Transthyretin-mediated (hATTR) Amyloidosis, Polyneuropathy",
      "High Cardiovascular Risk, Hypertension",
      "High Risk Cardiovascular Disease, Hypertension, High Cardiovascular Risk",
      "Hypercholesterolemia",
      "Hypertension",
      "IgA Nephropathy (IgAN), Berger Disease, Glomerulonephritis, IgA",
      "Nonalcoholic Steatohepatitis, NASH",
      "PH1, Primary Hyperoxaluria, RNAi Therapeutic, siRNA, AGT",
      "Paroxysmal Nocturnal Hemoglobinuria (PNH)",
      "Primary Hyperoxaluria Type 1 (PH1)",
      "Primary Hyperoxaluria, Primary Hyperoxaluria Type 1 (PH1)",
      "Respiratory Syncytial Virus Infections",
      "Solid Tumors",
      "TTR-mediated Amyloidosis",
      "TTR-mediated Amyloidosis, Amyloidosis, Hereditary, Amyloid Neuropathies, Familial, Familial Amyloid Polyneuropathies, Amyloid Neuropathies, Amyloidosis, Hereditary, Transthyretin-Related",
      "Transthyretin (TTR)-Mediated Amyloidosis",
      "Transthyretin (TTR)-Mediated Amyloidosis, Familial Amyloidotic Polyneuropathy (FAP), ATTR Amyloidosis, Familial Amyloid Neuropathies",
      "Transthyretin Amyloidosis",
      "Transthyretin Amyloidosis (ATTR) With Cardiomyopathy",
      "Transthyretin Amyloidosis With Cardiomyopathy",
      "Transthyretin Amyloidosis, Heart Failure, Heart Failure, Diastolic, Amyloidosis",
      "Transthyretin Mediated Amyloidosis (ATTR)",
      "Transthyretin-Mediated Amyloidosis, ATTR Amyloidosis",
      "Transthyretin-mediated Amyloidosis (ATTR Amyloidosis)",
      "Transthyretin-mediated Amyloidosis With Cardiomyopathy, ATTR Amyloidosis With Cardiomyopathy",
      "Type 2 Diabetes Mellitus (T2DM)",
      "ZZ Type Alpha-1 Antitrypsin Deficiency Liver Disease"
    ],
    "lead_stage": "phase_3"
  },
  "provenance": {
    "source": "ClinicalTrials.gov API v2",
    "timestamp": "2026-01-12T09:03:06.395626",
    "search_query": "Alnylam Pharmaceuticals",
    "url": "https://clinicaltrials.gov/search?term=Alnylam+Pharmaceuticals"
  }
}